In addition, CCL2-neutralizing antibody notably reduced the LNMAT1-transduced tumor burden in the LNs, which led to prolonged survival times of the tumor-bearing nude mice (Fig. 4j, k), suggesting that ablation of CCL2 could inhibit LNMAT1-induced LN metastasis. The gene discussed is DUXAP9; the disease is neoplasm.